James G. Stevenson

ORCID: 0000-0001-6542-9578
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmaceutical Practices and Patient Outcomes
  • Congenital Heart Disease Studies
  • Cardiac Valve Diseases and Treatments
  • Pharmaceutical studies and practices
  • Patient Safety and Medication Errors
  • Health Systems, Economic Evaluations, Quality of Life
  • Pharmaceutical Economics and Policy
  • Cardiovascular Function and Risk Factors
  • Biosimilars and Bioanalytical Methods
  • Pulmonary Hypertension Research and Treatments
  • Cardiac Imaging and Diagnostics
  • Cardiac Arrhythmias and Treatments
  • Coronary Artery Anomalies
  • Electronic Health Records Systems
  • Medication Adherence and Compliance
  • Infective Endocarditis Diagnosis and Management
  • Pharmacy and Medical Practices
  • Cardiac Structural Anomalies and Repair
  • Ultrasound in Clinical Applications
  • Vascular anomalies and interventions
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiovascular Issues in Pregnancy
  • Pleural and Pulmonary Diseases
  • Safe Handling of Antineoplastic Drugs
  • Atrial Fibrillation Management and Outcomes

Schrodinger (United States)
2023

University of Michigan
2012-2022

Omnicell (United States)
2021

University Hospital Crosshouse
2000-2017

Fresenius Kabi (Netherlands)
2017

Stevenson University
1976-2017

Eli Lilly (United States)
2017

University of Washington
1984-2016

Michigan Medicine
2001-2014

Dean College
2002-2013

A study was performed to quantify the personnel resources required manage drug shortages, define impact of shortages on health systems nationwide, and assess adequacy information available shortages.An online survey sent 1322 members American Society Health-System Pharmacists who were identified as directors pharmacy. Survey recipients asked identify which 30 most recent listed affected their system, actions taken shortage, rate each shortage. Employees responsible for completing predefined...

10.2146/ajhp110210 article EN American Journal of Health-System Pharmacy 2011-09-19

The M-mode echocardiographic findings of ventricular septal defect (VSD) are nonspecific. A specific pulsed Doppler (PDE) diagnosis VSD can be made by following the turbulent jet through septum. To assess sensitivity, specificity and limitations PDE VSD, 105 children undergoing cardiac catheterization were examined PDE. These had a variety defects, was in 46/51 (90%) who proven at catheterization. There one false positive for 98%. Factors influencing ability to diagnose include location...

10.1161/01.cir.58.2.322 article EN Circulation 1978-08-01

10.1016/s0894-7317(89)80053-7 article EN Journal of the American Society of Echocardiography 1989-05-01

Twenty-five patients with proven patent ductus arteriosus were examined by pulsed Doppler echocardiography (PDE) before invasive assessment. Ten had normal pulmonary artery pressures, and PDE, pandiastolic ductal flow. Fifteen elevation of mean pressure, all abbreviations diastolic PDE correctly distinguished between pressure those evidence hypertension; the ECG did not allow such differentiation. Detection hypertension complicating appears to be clinically useful.

10.1161/01.cir.60.2.355 article EN Circulation 1979-08-01

An update on scientific and regulatory challenges in the rapidly evolving field of biosimilar product development is presented.

10.2146/ajhp130119 article EN American Journal of Health-System Pharmacy 2013-10-31

The development of a patient-centered medical home (PCMH) health care model and the role pharmacists in PCMHs at University Michigan are described.In 2009, Blue Cross Shield (BCBSM) provided financial incentives to physician groups implement PCMH principles. A partnership was formed among department pharmacy, college faculty group practice Health System (UMHS) integrate clinical into eight general medicine practices. rationale that could assist managing chronic conditions by substituting or...

10.2146/ajhp110470 article EN American Journal of Health-System Pharmacy 2012-05-29

The movement away from fee-for-service models to those that emphasize quality of care and patient outcomes affords a unique opportunity for antimicrobial stewardship programs expand their value hospital administration. Antimicrobial participants must collaborate with administrators key stakeholders position themselves improve economic, process, measures. This will allow the establishment as essential components present future healthcare journey.

10.1093/cid/ciu566 article EN Clinical Infectious Diseases 2014-09-26

A prospective program to convert patients from parenteral oral antibiotics was evaluated over 12 months determine its pharmacoeconomic impact on antibiotic acquisition and length of hospital stay. Physicians meeting predetermined clinical criteria for mild moderate infections were contacted discuss potential alternative therapy. Clinical end points economic data followed in 242 (200 converted 42 not but criteria). No significant differences noted between the groups with regard demographic...

10.1002/j.1875-9114.1997.tb03709.x article EN Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 1997-03-04

Five male pediatric patients with primary ventricular tachycardia are described. Although three were initially in congestive heart failure due to the and extremely difficult manage, all have completely recovered, not taking medication, free of arrhythmia. Three required long-term management quinidine, a therapeutic goal controlling rather than abolishing No growth disturbances found those patients. A review reported cases revealed 71 infants children associated disease or systemic disorders;...

10.1161/01.cir.62.4.897 article EN Circulation 1980-10-01

A review of sexual dysfunction due to antihypertensive agents is presented. Sexual a relatively common complication drug therapy and has been associated with nearly all the agents. The physiology normal response, proposed mechanisms dysfunction, types disorders relative incidence rates individual are discussed. Since disturbance in function may lead poor compliance regimen, it important that clinician be familiar this topic. Information on detection antihypertensive-agent-induced patient...

10.1177/106002808401800204 article EN Drug Intelligence & Clinical Pharmacy 1984-02-01

Pharmacists will play a key role in evaluating biosimilars for formulary inclusion the United States. As defined by US law, biosimilar is biologic that highly similar to its reference product, notwithstanding minor differences clinically inactive components, and should not have meaningful from product safety, purity, potency. We review current European Union regulatory pathways biosimilars. Furthermore, we propose checklist of considerations ensure pharmacists thoroughly evaluate future...

10.1310/hpj4909-813 article EN Hospital Pharmacy 2014-09-01
Coming Soon ...